Current therapeutic leads for the treatment of autoimmune diseases: stem cell transplantation and inhibition of post-translational modifications of autoantigens

Author： Papanastasiou Anastasios D   Chatzantoni Kokona   Mouzaki Athanasia  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.3, Iss.10, 2008-10, pp. : 1255-1265

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Post-Translational Modifications of PTEN and their Potential Therapeutic Implications

By  

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-06 ,pp. : 536-547

Bentham Science Publishers

Access to resources Recommend Favorite

Post-Translational Modifications of Nuclear Co-repressor RIP140: A Therapeutic Target for Metabolic Diseases

By  

Current Medicinal Chemistry, Vol. 15, Iss. 4, 2008-02 ,pp. : 386-392

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of Post-Translational Modifications of G-Proteins as Probes to Study the Pancreatic #946; Cell Function: Potential Therapeutic Implications

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 2, Iss. 2, 2002-07 ,pp. : 129-139

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Post-translational Modifications in Huntington’s and Parkinson’s Diseases

By  

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5085-5092

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Post-translational Modifications to Target Memory-related Diseases

By  

Current Pharmaceutical Design, Vol. 19, Iss. 28, 2013-04 ,pp. : 5065-5075

Bentham Science Publishers

Access to resources Recommend Favorite